Inspire Medical Systems (INSP) Tops Q2 EPS by 38c, Beats on Revenue; Offers FY26 Revenue Guidance

Inspire Medical Systems (NYSE: INSP) reported Q2 EPS of $0.14, $0.38 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $200.6 million versus the consensus estimate of $194.67 million.

GUIDANCE:

Inspire Medical Systems sees FY2026 revenue of $835-875 million, versus the consensus of $843 million.

For earnings history and earnings-related data on Inspire Medical Systems (INSP) click here.

You May Also Be Interested In

• Vicor raises Q3 2026 revenue guidance on new licensing deal
• StoneX Reiterates Buy Rating on Criteo S.A. (CRTO) as Open AI Integration Shows Encouraging Early Signals
• Coherent launches PhotonLink integrated optics platform for AI datacenters